QUICK POLL
Which antihypertensive agents have been shown to reduce the risk of skin cancer?
About Imedex
Imedex® has provided the best in accredited, independent continuing medical education for over 20 years. We develop high quality, scientific programs that translate the latest research into clinically relevant information. The programs have a proven sustained impact on disease management, exceptional organization, and outstanding educational value.
Imedex develops and manages over 125 live, enduring, and e-learning continuing medical educational projects a year. With over 14,000 live meeting attendees and 120,000 e-learning experiences, Imedex truly educates the global healthcare community. Our programs focus on impacting the clinical management of patients around the world in the therapy areas of oncology, hematology, gastroenterology, infectious disease, urology, CNS, cardiology, and psychiatry. Our goal is to ensure that our education is the best medicine®.
Imedex offers:
- Live Meetings
- ELearning
- Printed Publications
- Accreditation
- Scientific Development
- Accreditation
- Logistics Management
- Project Marketing
- Graphic and Web Design
- Digital Media Services
- Custom Application Development
- Registration and Customer Service
THE NOCR
Established in 1993, the NOCR is a self-registered network of 30,000+ worldwide oncology professionals. Members of the NOCR have clearly communicated their preference for Imedex’s educational content, unique format, and highly sought-after faculty by increasing their participation in both live and e-learning activities year after year.
 |
 |
PHYSICIAN SPECIALTIES
 |
 |
- 30,000+ email addresses (US: 21,500+ & INTERNATIONAL: 8,400+)
- In addition to NOCR members, 17,000+ oncology and hematology professionals are in the Imedex network outside of the US
- 12,987 attendees at Imedex oncology/hematology live proprietary meetings in 2007
- Live oncology meetings held in 15 countries
- 147 countries represented at live meetings
- 30,000+ worldwide oncology professionals in our network
Our established relationships with the leading investigators and researchers in medicine, and some of the world's most prestigious societies, make our educational offerings the most effective in the industry. These specialists in cancer research, leading oncologists, and practicing clinicians are widely recognized international authorities who provide fair and balanced presentations of the most clinically-significant and relevant information.
2007 ONCOLOGY CHAIRS (does not include symposia and enduring materials chairs):
| James O. Armitage, MD Volker Budach, MD, PhD Maureen Major Campos, RN, MS Bertrand Coiffier, MD Morton Coleman, MD Mario Dicato, MD Meletios Dimopoulos, MD Andreas du Bois, MD, PhD Alexander M.M. Eggermont, MD, PhD Ronald Feld, MD Richard R. Furman, MD Richard M. Goldberg, MD William Gradishar, MD, FACP Axel Grothey, MD Daniel G. Haller, MD Peter G. Harper, MD |
Yoon-Koo Kang, MD |
Derek Raghavan, MD, PhD Abram Recht, MD Mace L. Rothenberg, MD Hope Rugo, MD Miguel A. Sanz, MD, PhD Giorgio V. Scagliotti, MD, PhD Richard T. Silver, MD Eric J. Small, MD Mark S. Soloway, MD Vernon Sondak, MD Jerry L. Spivak, MD Eric Van Cutsem, MD Martin J. van den Bent, MD, PhD Jan B. Vermorken, MD, PhD W.K. Alfred Yung, MD |
*700+ experts participated as Imedex faculty members in 2007
SCIENTIFIC ADVISORY BOARD:
To ensure that we are continuously meeting the needs of our audience, we have convened a panel of national experts in hematology and oncology. Their role is to provide balanced, unbiased, and objective advice on the educational gaps and needs they perceive among community physicians, academic physicians, and other oncology professionals. Our advisors consult with us on the most efficient and effective means to address those educational gaps and fulfill those educational needs, with the ultimate goals of improving patient care and outcome.
Members:
James O. Armitage, MD Dean Bajorin, MD Rodolfo Bordoni, MD |
Jorge Cortes, MD Axel Grothey, MD Thomas Lynch, MD Robert Orlowski, MD, PhD |
Ruth O’Regan, MD Facilitators: James M. Epstein, MD |
At Imedex, we develop high quality, scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disase management.
Imedex strictly adheres to the most recent guidelines from the ACCME, ACPE, AdvaMed, AMA, OIG, and PhRMA allowing us to provide a global, fully-integrated, and multi-accredited platform for continuing medical education.
Accredited by:
 |
Accreditation Council for Continuing Medical Education since 1993 (ACCME) |
 |
Accreditation Council for Pharmacy Education since 2005 (ACPE) |
*95% of Imedex's attendees increased their professional knowledge after participating in one of our live activities
A variety of live presentation formats to satisfy all preferences:
-Didactic presentations
-Interactive audience response system
-Debates
-Roundtable discussions
-Meet the Expert sessions
-Case presentations
-Multi-disciplinary panels
CLINICALLY RELEVANT
-63% will change their disease management approach
-95% exchange conference information with colleagues
*Survey statistics based on the average of responses to a survey taken 3 months after participation in a live, multi-day Imedex meeting
OUTCOMES MEASUREMENT
Evaluation data are collected at the conclusion of every live activity and again 3 months later to gauge lasting educational impact.
 |
 |
 |
AUDIENCE BREAKDOWN FOR ALL LIVE MEETINGS IN 2007
IMEDEX PROPRIETARY LIVE MEETINGS IN 2007
364.5 – total number of oncology credit hours offered at Imedex meetings in 2007
TYPES OF MEETINGS
-5,839 attendees at US meetings in 2007
-7,086 attendees at International Oncology meetings in 2007
Recognizing the busy schedule of healthcare professionals, Imedex offers a complete suite of innovative e-learning products. With clinically-relevant, accredited material delivered in 6 user-friendly formats, Imedex is always on the leading edge of educational content delivery.
 |
Best of the Day: A daily synopsis by renowned experts at influential international conferences. |
 |
Email Case: A convenient and interactive way to access clinically relevant information with discussion authored by a renowned expert. |
 |
Webcasts: Video of nationally and internationally recognized experts giving their state-of-the-art presentations at Imedex live meetings. Also available as podcasts. |
 |
Clinical Case Review: Recreates the traditional tumor board setting in which real patient cases are presented by real community oncologists who analyze and discuss them just as they do in community hospitals. |
 |
New Frontiers: A renowned expert reviews new clinical trials, provides insight into the immediate and future uses of the new trial regimens, and describes the future frontiers of the therapies being discussed. |
 |
Interactive Online Monograph: An innovative e-learning activity featuring 2-3 case scenarios or debates with evidence-based commentary provided by experts in the therapeutic area being discussed. |
Imedex develops a range of print materials, accredited for educational credit and a valuable permanent reference. Some of the many options include monographs, symposium highlights, proceedings, and supplements to established medical journals.
IMEDEX AND THE ENVIRONMENT
As discussions about the environment have become more common, the desire to bring sustainability and assure the long-term survival of our planet by conservation of resources has become important. For companies, environmental responsibility and profitability go hand-in-hand. By shifting our production methods to reduce and reuse waste materials, Imedex can conserve energy and support sustainable forestry practices that are fundamental to mitigating climate change.
